$WTW

Willis Towers Watson (WTW) investor files Form 144 for 730-share stock sale

A Willis Towers Watson (WTW) shareholder filed a Form 144 to sell 730 shares of WTW common stock on NASDAQ through Fidelity Brokerage Services LLC, with an aggregate value of $250,171.73, planned for 08/10/2026. The filing also notes 725 shares and 5 shares became eligible for sale via restricted stock vesting on 04/01/2025 and 04/15/2025, respectively.

Original reporting
Published Aug 10, 2026, 9:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 1:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$WTW
Neutral
medium confidence
Mentioned
$WTW
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$WTWNeutralLow
01

Why it matters

This disclosure mainly informs traders about potential near-term share supply from a specific planned sale, without indicating a change in business outlook.

02

Market read

Traders may monitor for follow-through selling around the stated date, but the disclosed size suggests limited fundamental impact.

03

What to watch

The article does not confirm whether any shares were actually sold, nor does it quantify total insider selling activity beyond this filing.

Relevance 4/10Novelty 4/10Timing: dated 08/10/2026 for the planned sale execution

Background

Form 144 filings are used to provide transparency when insiders or shareholders plan to sell restricted or large blocks of stock.

Company-level read

Ticker impact

$WTWNeutralMedium confidence
Context

WTW investor filed a Form 144 to sell 730 shares on 08/10/2026, totaling about $250,171.73 on NASDAQ.

Expected impact

Low near-term impact; any move is likely sentiment-driven and limited unless follow-on selling is large or frequent.

Evidence & confidence

The filing discloses intent to sell a relatively small block (730 shares) and does not state executed sales, proceeds use, or new company fundamentals.

Market effects

Minimal, as this is a single-company planned sale with no sector-wide signal.

None indicated; NASDAQ-listed issuer only.

None indicated.

Counterpoint

Planned Form 144 selling often reflects routine liquidity needs or pre-scheduled sales, so it may not predict sustained downside.

Key entities

  • Willis Towers Watson

    NASDAQ-listed issuer whose shareholder filed Form 144 for a planned sale of 730 shares.

  • Fidelity Brokerage Services LLC

    Brokerage through which the planned sale is to be executed, per the filing summary.

Related articles

$WTWLow

Analysts’ Opinions Are Mixed on These Financial Stocks: Willis Towers Watson (WTW) and Raymond James Financial (RJF)

Analysts at TD Cowen maintained Buy ratings on Willis Towers Watson (WTW) with a $455 target, and Hold on Raymond James Financial (RJF) with a $161 target. WTW closed at $335.46, near its 52-week high, while RJF closed at $177.93. Analyst consensus for WTW is Moderate Buy with a $374.87 average target, and for RJF is Moderate Buy with a $185.80 average target.

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Willis Towers Watson (WTW) reported Q2 2026 results on an earnings call. Management cited 5% organic revenue growth, adjusted diluted EPS of $3.35 (+17% YoY), and a 19.5% adjusted operating margin (+100 bps). It outlined Propel, targeting $400 million run-rate savings by 2028 and enterprise margin of about 30%, plus $450 million Q2 buybacks.

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Willis Towers Watson (WTW) reported Q2 2026 results on its earnings call. Management cited 5% organic revenue growth, adjusted diluted EPS of $3.35 (+17% YoY), and a 19.5% adjusted operating margin (+100 bps). The company targets $400m run-rate savings by 2028 from a ~$625m AI investment and $360m free cash flow in the first half of 2026.

$WTWMed

Why is Willis Towers Watson stock climbing today?

Willis Towers Watson (WTW) shares rose about 1.5% after Q2 results beat expectations and prompted analyst target increases. According to the company, adjusted EPS was $3.35 vs $3.13 consensus, revenue about $2.47B vs $2.41B, with 5% organic growth. Goldman raised its target to $385 and UBS to $405 (both Buy), while Citigroup downgraded to Neutral with a $345 target.

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Carl A. Hess Chief Financial Officer - Andrew Krasner President of Health, Wealth & Career - Julie Gebauer President of Risk & Broking - Lucy Clarke TAKEAWAYS Organic Revenue Growth -- 5%, reflecting strength in the Risk & Broking segment and steady performance in Health, Wealth & Career.